Journals / Geriatrik Bilimler Dergisi / 2022 / Cilt: 5 - Sayı: 3

The Relationship Between Homocysteine Levels and Frailty in Older Women

Yaşlı Kadınlarda Homosistein Düzeyinin Kırılganlıkla İlişkisi

Pages
64–71
Publication Date
2022-12-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Dementia was diagnosed in 19.0% of patients with low HC and 37.3% of patients with HHC (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Fraility; that is a geriatric syndrome associated with an increased risk of falls, disability, long-term care and death.
📊
Key Findings & Data:Deficiencies of vitamin B12 and folic acid cause hyperhomocysteinemia (HHC).
💡
Conclusion & Impact:Dementia was diagnosed in 19.0% of patients with low HC and 37.3% of patients with HHC (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:kırılganlık · homosistein · vitamin B12

Abstract

Aim: Fraility; that is a geriatric syndrome associated with an increased risk of falls, disability, long-term care and death. Therefore, it is very important to find indicators that may be associated with fraility in order to detect and prevent fraility in advance. Deficiencies of vitamin B12 and folic acid cause hyperhomocysteinemia (HHC). HHC is associated with many negative outcomes such as atherosclerosis, thromboembolism, sarcopenia and bone resorption. All of these make HHC an important risk factor for frailty. Our aim in the study is to reveal the relationship between homocysteine (HC) level and frailty in elderly women. Material and Methods: In this retrospective study, we included 275 female patients who were over 50 years of age and whose file records were thorough. The patients were divided into 2 groups according to their HS levels. 17.2 mmol/L, which corresponds to the 75th percentile, was taken as the cut-off value for plasma homocysteine (HC) levels of the patients. For all patients; the number of drugs used, sociodemographic characteristics, comorbidities, presence of geriatric syndrome, laboratory results, comprehensive geriatric assessment (CGA) parameters and frailty status were recorded, and comparisons between groups were made. Findings: The mean age of the patients included in the study was 75.35±7.41 years. Dementia was diagnosed in 19.0% of patients with low HC and 37.3% of patients with HHC (p

Özet

Amaç: Kırılganlık; düşme, dizabilite, uzun süreli bakım alma ve ölüm riski ile ilişkilendirilen bir geriatrik sendromdur. Bu nedenle kırılganlığın önceden saptanabilmesi ve önlenebilmesi için kırılganlık ile ilişkili olabilecek belirteçlerinin bulunması oldukça önemlidir. Vitamin B12 ve folik asit eksikliği hiperhomosisteinemiye (HHS) neden olmaktadır. HHS; ateroskleroz, tromboemboli, sarkopeni, kemik rezorbsiyonu gibi birçok olumsuz sonuç ile ilişkilendirilmektedir. Tüm bunlar HHS’yi kırılganlığın önemli bir risk faktörü olarak karşımıza çıkarmaktadır. Çalışmadaki amacımız yaşlı kadınlarda homosistein (HS) düzeyi ile kırılganlık ilişkisini ortaya koymaktır. Gereç Yöntem: Retrospektif olarak tasarlanan çalışmamıza 50 yaş üstü, dosya kayıtlarında eksik olmayan 275 kadın hasta dahil edildi. Hastalar HS düzeylerine göre 2 gruba ayrıldı. Hastaların plazma homosistein (HS) değeri için 75. persentile denk gelen 17.2 mmol/L değeri kesme değer olarak alındı. Tüm hastaların kullandıkları ilaç sayısı, sosyodemografik özellikleri, komorbiditeleri, geriatrik sendrom varlığı, laboratuvar sonuçları, ayrıntılı geriatrik değerlendirme (AGD) parametreleri ve kırılganlık durumları kaydedilerek gruplar arası karşılaştırma yapıldı. Bulgular: Çalışmaya dahil edilen hastaların yaş ortalaması 75.35±7.41’di. HS seviyesi düşük olan hastaların %19,0’ında, HHS olanların %37,3’ünde demans tanısı vardı(p

🔖

Cite This Article

İDİL, E., MAHŞER, A. Ç., ÖNTAN, M. S. (2022). The Relationship Between Homocysteine Levels and Frailty in Older Women. Geriatrik Bilimler Dergisi, Cilt: 5 - Sayı: 3, 64–71. https://ajindex.com/articles/868332

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. https://population.un.org/wpp/Graphs/DemographicProfiles, Erişim Tarihi: 24.12.2022 2. Bandeen-Roche K, Xue QL, Ferrucci L, et al. Phenotype of frailty: Characterization in the women’s health and aging studies. Journals Gerontol - Ser A Biol Sci Med Sci. 2006
  2. 61(3):262–6. 3. Abellan van Kan G, Rolland Y, Bergman H, et al. The I.A.N.A Task Force on frailty assessment of older people in clinical practice. J Nutr Health Aging. 2008 Jan
  3. 12(1):29-37. 4. Hoogendijk EO, Afilalo J, Ensrud KE, et al. Frailty: Implications for clinical practice and public health. Lancet. 2019 Oct 12
  4. 394(10206):1365-1375. 5. Fried LP, Tangen CM, Walston J, et al. Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001 Mar
  5. 56(3):M146-56. 6. Nowak A, Hubbard RE. Falls and frailty: lessons from complex systems. J R Soc Med. 2009 Mar
  6. 102(3):98-102. 7. Song X, Mitnitski A, Rockwood K. Prevalence and 10-year outcomes of frailty in older adults in relation to deficit accumulation. J Am Geriatr Soc. 2010 Apr
  7. 58(4):681-7. 8. Op Het Veld LPM, de Vet HCW, van Rossum E, et al. Substitution of Fried's performance-based physical frailty criteria with self-report questions. Arch Gerontol Geriatr. 2018 Mar-Apr
  8. Björkman IK, Fastbom J, Schmidt IK, et al. Pharmaceutical Care of the Elderly in Europe Research (PEER) Group. Drug-drug interactions in the elderly. Ann Pharmacother. 2002 Nov
  9. 36(11):1675-81. 10. Picca A, Coelho-Junior HJ, Calvani R, et al. Biomarkers shared by frailty and sarcopenia in older adults: A systematic review and meta-analysis. Ageing Res Rev. 2022 Jan
  10. 101530. 11. Strandberg TE, Pitkälä KH. Frailty in elderly people. Lancet. 2007 Apr 21
  11. 369(9570):1328-1329. 12. Temel İ, Özerol E Homosistein metabolizma bozuklukları ve vasküler hastalıklarla ilişkisi. İnönü Üniversitesi Tıp Fakültesi Dergisi, 2002
  12. 9(2) 149-157 13. Xu R, Huang F, Wang Y et al. Gender- and age-related differences in homocysteine concentration: a cross-sectional study of the general population of China. Sci Rep. 2020 Oct 15
  13. 10(1):17401. 14. Nader, S., Robinson, K. A Recognized Risk Factor. Editör: Foody J.M. Preventive Cardiology. New Jersey, Humana Totowa Press, 2001, 221–231 15. Depeint F, Bruce WR, Shangari N, et al. Mitochondrial function and toxicity: role of B vitamins on the one-carbon transfer pathways. Chem Biol Interact. 2006 Oct 27
  14. 163(1-2):113-32. 16. Veeranki S, Tyagi SC. Defective homocysteine metab